PLoS ONE (Jan 2017)

Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas.

  • Lisa A Feldman,
  • Marie-Sophie Fabre,
  • Carole Grasso,
  • Dana Reid,
  • William C Broaddus,
  • Gregory M Lanza,
  • Bruce D Spiess,
  • Joel R Garbow,
  • Melanie J McConnell,
  • Patries M Herst

DOI
https://doi.org/10.1371/journal.pone.0184250
Journal volume & issue
Vol. 12, no. 9
p. e0184250

Abstract

Read online

BackgroundTumour hypoxia limits the effectiveness of radiation therapy. Delivering normobaric or hyperbaric oxygen therapy elevates pO2 in both tumour and normal brain tissue. However, pO2 levels return to baseline within 15 minutes of stopping therapy.AimTo investigate the effect of perfluorocarbon (PFC) emulsions on hypoxia in subcutaneous and intracranial mouse gliomas and their radiosensitising effect in orthotopic gliomas in mice breathing carbogen (95%O2 and 5%CO2).ResultsPFC emulsions completely abrogated hypoxia in both subcutaneous and intracranial GL261 models and conferred a significant survival advantage orthotopically (Mantel Cox: p = 0.048) in carbogen breathing mice injected intravenously (IV) with PFC emulsions before radiation versus mice receiving radiation alone. Carbogen alone decreased hypoxia levels substantially and conferred a smaller but not statistically significant survival advantage over and above radiation alone.ConclusionIV injections of PFC emulsions followed by 1h carbogen breathing, radiosensitises GL261 intracranial tumors.